Related Experiment Video
Updated: Jul 4, 2026
10:19
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
[Diagnostic criteria in acute neuromyelitis]
Cristina Panea1, Simona Petrescu, Pop Monica
1Clinica de Neurologie a Spitalului Universitar de Urgenţă Elias Bucureşti.
Oftalmologia (Bucharest, Romania : 1990)
|June 12, 2008
Summary
Neuromyelitis optica (NMO), or Devic disease, is a CNS demyelinating condition often misdiagnosed as multiple sclerosis. Revised 2006 criteria, including NMO-IgG biomarker detection, improve diagnostic accuracy.
Area of Science:
- Neurology
- Immunology
- Neuroimmunology
Context:
- Neuromyelitis optica (NMO), or Devic disease, is a rare inflammatory demyelinating disease of the central nervous system.
- NMO is frequently misdiagnosed as multiple sclerosis (MS), leading to delayed or incorrect treatment.
- Previous diagnostic criteria proposed in 1999 lacked sufficient specificity.
Purpose:
- To present the clinical, imaging (MRI), serological, and cerebrospinal fluid findings in NMO.
- To detail the revised 2006 diagnostic criteria for NMO.
- To highlight the role of the neuromyelitis optica immunoglobulin G (NMO-IgG) biomarker in differentiating NMO from MS.
Summary:
- The article discusses Neuromyelitis Optica (NMO), a central nervous system inflammatory demyelinating disease.
- It reviews the 2006 revised diagnostic criteria for NMO, which are 99% sensitive and 90% specific for differentiating NMO from MS.
- Key features include clinical presentation, MRI findings, CSF analysis, and serological markers, notably the NMO-IgG antibody targeting aquaporin 4.
Impact:
- The revised criteria and NMO-IgG biomarker significantly enhance the accurate diagnosis of NMO.
- Improved diagnostic accuracy facilitates timely and appropriate therapeutic interventions for NMO patients.
- Distinguishing NMO from MS is crucial for patient management and prognosis.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...